Incremental innovation consists of introducing in Brazilian market existing assets in the world or promoting incremental improves, such as new associations, formulations, therapeutic indications, and application of different technologies in existing assets, thus bringing innovative proposals to understand the needs of doctors and patients.

Perspectives for the pharmaceutical industry point out to incremental innovation and nanotechnology as promising areas for the next years. Foreseeing this trend, we created, in 2016, the Nanotechnology Innovation Laboratory Enterprise (NILE), laboratory to explore nanotechnology, in partnership with the Swedish company Ferring Pharmaceuticals.